Author Information
Alemka Markotić is a renowned researcher affiliated with the University Hospital for Infectious Diseases Dr Fran Mihaljević in Zagreb, Croatia. She is also associated with the School of Medicine at the Catholic University of Croatia in Zagreb and the Faculty of Medicine at the University of Rijeka in Rijeka, Croatia. Her research primarily focuses on infectious diseases, with a significant contribution to the understanding and management of viral infections, particularly in the context of the COVID-19 pandemic.Research Contributions
Alemka Markotić has made substantial contributions to the field of infectious diseases through her research on viral infections, vaccine efficacy, and immunological responses. Her recent work includes investigations into SARS-CoV-2, where she explored monoclonal antibodies targeting the virus's proteins, the decline of antibody levels post-vaccination, and the potential for improved standardization of therapeutic antibodies during epidemics. Additionally, she has contributed to studies on mucosal immunity in response to different vaccine administration routes and has identified suitable cell models for SARS-CoV-2 infection studies.Aliases
Throughout her academic and research career, Alemka Markotić has been referenced by several aliases, including A.- Markotic, A Markotic, A Markotić, and A. Markotic. These variations appear in different publications and citations, reflecting her widespread recognition in the scientific community.Publication and Citation Metrics
| Metric |
Value |
| Total Citations |
1712 |
| h-Index |
24 |
| Number of Papers |
245 |
